EverSource Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
1,164
+10
+0.9% +$2.07K 0.01% 944
2026
Q1
$259K Buy
1,154
+363
+46% +$90.5K 0.01% 916
2025
Q4
$191K Buy
791
+31
+4% +$7.93K 0.01% 968
2025
Q3
$208K Buy
760
+10
+1% +$2.73K 0.01% 883
2025
Q2
$194K Buy
750
+186
+33% +$44.4K 0.01% 879
2025
Q1
$126K Buy
564
+157
+39% +$36.7K 0.01% 825
2024
Q4
$93.1K Buy
407
+12
+3% +$2.89K 0.01% 929
2024
Q3
$96.5K Buy
395
+32
+9% +$7.15K 0.01% 797
2024
Q2
$77.4K Sell
363
-113
-24% -$22.9K 0.01% 905
2024
Q1
$102K Buy
476
+33
+7% +$6.05K 0.01% 696
2023
Q4
$76.2K Buy
443
+258
+139% +$39.6K 0.01% 741
2023
Q3
$27.4K Buy
185
+128
+225% +$23.1K ﹤0.01% 1018
2023
Q2
$12.5K Sell
57
-9
-14% -$2.01K ﹤0.01% 1350
2023
Q1
$14.5K Buy
66
+36
+120% +$7.81K ﹤0.01% 1212
2022
Q4
$6.24K Sell
30
-369
-92% -$81.1K ﹤0.01% 1516
2022
Q3
$87K Buy
399
+353
+767% +$80.3K 0.02% 465
2022
Q2
$10K Sell
46
-31
-40% -$6.6K ﹤0.01% 1040
2022
Q1
$18K Sell
77
-12
-13% -$2.9K ﹤0.01% 744
2021
Q4
$23K Buy
+89
New +$23.1K 0.01% 631

Other funds holding RMD

EverSource Wealth Advisors's RMD Position: Q2 2026 in Review

EverSource Wealth Advisors increased its ResMed (RMD) stake by 0.87% in Q2 2026, buying an estimated $2.07K and bringing the position to 1,164 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #944.

EverSource Wealth Advisors first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $259K in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • EverSource Wealth Advisors held 1,164 shares of ResMed worth $227K as of Q2 2026.
  • EverSource Wealth Advisors bought 10 ResMed shares in Q2 2026, an estimated $2.07K.
  • ResMed made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #944 holding.
  • EverSource Wealth Advisors first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's ResMed position peaked at $259K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.